SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: JCS who wrote (847)10/19/1998 5:29:00 PM
From: Dr. John M. de Castro  Read Replies (3) | Respond to of 887
 
This is a very bad deal for DEPO stockholders. Skye is getting DEPO for book value and nearly cash value. in addition there will be very little premium paid for success of DepoCyt or DepoMorph. Those of us who absorbed all of the risk and took a beating, will now get virtually none of the benefit. I am completely exasperated. Fred Middleton and John Longenecker should be drawn and quartered for entering into such a deal. I'll bet they have arranged a hell of a deal for themselves. One of them will probably get the cushy seat on the Skye board and who knows what else.

It is clear however, that we're getting screwed.

John de C



To: JCS who wrote (847)10/20/1998 10:39:00 AM
From: StockDoc  Respond to of 887
 
Interesting that Europeans seem to like this Depotech business.
Hope it works out well for both parties.



To: JCS who wrote (847)10/21/1998 4:13:00 PM
From: StockDoc  Read Replies (1) | Respond to of 887
 
As someone noted earlier, I agree that anyone buying this stock makes a favor to DEPO management and other salaried employees. There's no indication that science gets better.
As of Skyepharma, I'm not sure about their motivations. They might aim at the DURA path (expansion by cheap acquisition of anything for sale) with short term gains in mind. Nothing wrong with that if you know when to get out. There's no medical need for sustained release oral paroxetine.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News